- Trials with a EudraCT protocol (23)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
23 result(s) found for: Emotional Stress.
Displaying page 1 of 2.
EudraCT Number: 2012-001288-58 | Sponsor Protocol Number: 40122 | Start Date*: 2012-05-21 | |||||||||||
Sponsor Name:Academic Medical Center | |||||||||||||
Full Title: Boosting oxytocin after trauma: The effects of intranasal oxytocin administration on emotional and motivational brain processes in PTSD | |||||||||||||
Medical condition: Posttraumatic Stress Disorder (PTSD) according to criteria in the DSM-IV | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004823-66 | Sponsor Protocol Number: ELTCAN1 | Start Date*: 2019-04-17 | |||||||||||
Sponsor Name:Radboudumc | |||||||||||||
Full Title: Early-life stress, the endocannabinoid system, and fear memory extinction | |||||||||||||
Medical condition: healthy volunteers | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000712-30 | Sponsor Protocol Number: ABR-71432 | Start Date*: 2021-06-07 | |||||||||||
Sponsor Name:Radboudumc | |||||||||||||
Full Title: Targeted glucocorticoid administration to improve safety learning in PTSD patients with HPA axis dysregulation | |||||||||||||
Medical condition: Posttraumatic Stress Disorder (PTSD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002358-22 | Sponsor Protocol Number: C1201 | Start Date*: 2012-08-06 | |||||||||||
Sponsor Name:Biologische Heilmittel Heel GmbH | |||||||||||||
Full Title: NEUPRO DB, efficacy profile of Neurexan in an experimental acute stress setting – an explorative double blind study in healthy probands | |||||||||||||
Medical condition: Neurexan to be effective in fostering mental balance by reducing tension and nervousness during acute stress setting in healthy probands | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002359-40 | Sponsor Protocol Number: C1202 | Start Date*: 2012-07-18 | |||||||||||
Sponsor Name:Biologische Heilmittel Heel GmbH | |||||||||||||
Full Title: NEUPRO OL, Efficacy profile of Neurexan® in an experimental acute stress setting – an explorative open-label study in healthy probands | |||||||||||||
Medical condition: Neurexan to be effective in fostering mental balance by reducing tension and nervousness during acute stress setting in healthy probands | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001802-32 | Sponsor Protocol Number: C1501 | Start Date*: 2015-08-14 | |||||||||||
Sponsor Name:Biologische Heilmittel Heel GmbH | |||||||||||||
Full Title: Neuronal correlates of Neurexan® action in mildly to moderately stressed probands - a randomized, placebo-controlled, double-blind, cross-over trial of mode of action and response prediction by fun... | |||||||||||||
Medical condition: mildly to moderately stressed probands | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001718-13 | Sponsor Protocol Number: MP18 | Start Date*: 2019-10-18 |
Sponsor Name:MAPS Europe B.V. | ||
Full Title: An Open- Label, Phase 2, Multicenter Feasibility Study if Manualized MDMA-Assisted Psychotherapy with an fMRI sub-study Assessing Changes in Brain Activity in Subjects with Posttraumatic Stress Dis... | ||
Medical condition: post-traumatic stress disorder (PTSD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) CZ (Completed) NO (Completed) DE (Completed) GB (GB - no longer in EU/EEA) ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002097-38 | Sponsor Protocol Number: ABR62020 | Start Date*: 2018-06-05 |
Sponsor Name:University Medical Centre Utrecht | ||
Full Title: SAMe as an epigenetic treatment of depression in people with childhood trauma, a double blind placebo-controlled trial | ||
Medical condition: Depressive episode in people with childhood trauma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000603-12 | Sponsor Protocol Number: 80655 | Start Date*: 2022-08-05 |
Sponsor Name:Radboud University | ||
Full Title: Oxytocin and reactivity to infant signals in mothers with postpartum depression | ||
Medical condition: We examine the effects of oxytocin on mother-infant interaction among mothers with a postpartum depression | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-022686-10 | Sponsor Protocol Number: 578001.01.012 | Start Date*: 2011-06-08 |
Sponsor Name:Dr. W. Schwabe GmbH & Co. KG | ||
Full Title: Multi-centre, open-label clinical trial to evaluate the efficacy and safety of Rhodiola rosea extract WS® 1375 in Subjects with Burnout Symptoms | ||
Medical condition: Burnout symptoms like exhaustion, fatigue, mild anxiety, mood disturbances | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-003331-10 | Sponsor Protocol Number: HC03 | Start Date*: 2017-10-16 |
Sponsor Name:Leiden University | ||
Full Title: Acute effects of 40 mg cortisol on emotion and cognition. | ||
Medical condition: None. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-000295-41 | Sponsor Protocol Number: Ro-002/05 | Start Date*: 2006-05-29 |
Sponsor Name:Universität zu Köln | ||
Full Title: Double-blind,placebo-controlled cross-over study for evaluation of the efficacy of the PDE-5-inhibitor vardenafil on the peripheral perfusion and the clinical symptomatology of patients with Raynau... | ||
Medical condition: Raynaud´s disease (RD) is defined as episodic, painful, cold- or emotional stress-triggered vasospasms of the digital arteries and precapillary arterioles for up to 30 minutes with or without under... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-004840-36 | Sponsor Protocol Number: CHDE-1 | Start Date*: 2015-09-03 |
Sponsor Name:Hevert-Arzneimittel GmbH & Co. KG | ||
Full Title: Proof of effectiveness of Calmvalera Hevert using qantitative measurement of electrical brain activity on 24 subjects during image and video-mediated cognitive and emotional stress. A double-blind,... | ||
Medical condition: Subjects who suffer from exam nerves | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-017806-36 | Sponsor Protocol Number: CRC287 | Start Date*: 2010-11-03 | |||||||||||
Sponsor Name:University of Surrey | |||||||||||||
Full Title: Effect of Vitano® on physiological and psychological responses to psychological stress assessed under laboratory conditions and in everyday life. | |||||||||||||
Medical condition: Psychological stress | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-003941-42 | Sponsor Protocol Number: B4Z-SO-LY15 | Start Date*: 2005-02-11 |
Sponsor Name:Eli Lilly Sweden AB | ||
Full Title: A Randomised, Double Blind Placebo Controlled Study of the Broader Efficacy of Atomoxetine Hydrochloride in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Swedish Children and ... | ||
Medical condition: Attention-Deficit/Hyperactivity Disorder (ADHD) is a common psychiatric disorder that has its onset in childhood, and that is estimated to occur in 3% to 6% of school-age children. ADHD is characte... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-013468-37 | Sponsor Protocol Number: Protocol code BA7 | Start Date*: 2010-09-29 | ||||||||||||||||
Sponsor Name:Royal National Hospital for Rheumatic Disease | ||||||||||||||||||
Full Title: A short-term open-label single site pilot study evaluating the use of asasantin retard therapy in the management of Raynaud’s phenomenon. | ||||||||||||||||||
Medical condition: Primary Raynaud's Phenomenon and Systemic Sclerosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001592-33 | Sponsor Protocol Number: 0204 | Start Date*: 2020-11-17 | |||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||
Full Title: Maternal Mental Health (MAMA) Study. Short time estrogen as a candidate strategy to prevent postpartum depression in a high-risk group | |||||||||||||
Medical condition: Perinatal depression with postpartum onset | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004533-13 | Sponsor Protocol Number: EFC13470 | Start Date*: 2015-07-17 | |||||||||||
Sponsor Name:Sanofi-aventis recherche & développement | |||||||||||||
Full Title: A 21-Week, Open-label, Randomized, Controlled, Parallel-group, Multi-center Study Evaluating the Efficacy and Safety of HOE901-U300 Administered According to a Device-Supported Treat-to-target Regi... | |||||||||||||
Medical condition: Type 2 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001085-17 | Sponsor Protocol Number: P1V-S01-03-06 | Start Date*: 2007-08-22 | |||||||||||
Sponsor Name:University of Bristol | |||||||||||||
Full Title: Further development of a new model of GAD: The effect of a clinically effective and non−effective dose of lorazepam on CO2 induced anxiety | |||||||||||||
Medical condition: Generalized Anxiety Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000315-32 | Sponsor Protocol Number: 523079.01.113 | Start Date*: 2016-09-02 | |||||||||||
Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG | |||||||||||||
Full Title: Clinical Trial to Explore Treatment Effects of Ginkgo biloba Extract EGb 761® in Patients with Chronic Tinnitus and Effect Modification by Etiology, Biological Factors and Concomitant Pathologies. | |||||||||||||
Medical condition: Chronic Tinnitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.